Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 2
2024 pubmed 2 citations

Polysorbate 80 coated chitosan nanoparticles for delivery of α-melanocyte stimulating hormone analog (NDP-MSH) to the brain reverse cognitive impairment related to neuroinflammation produced by a high-fat diet (HFD).

Herrera. Guadalupe G; Scimonelli. Teresa T; Lasaga. Mercedes M; Granero. Gladys G; Onnainty. Renée R

Key Findings

  • Polysorbate‑80 coated chitosan nanoparticles successfully delivered NDP‑MSH to the rat brain within 2 hours.
  • The delivered NDP‑MSH restored contextual fear memory impaired by short‑term and long‑term high‑fat diet exposure.
  • Nanoparticle delivery improved the stability and brain availability of NDP‑MSH compared with the peptide alone.

Practical Outcomes

  • For now, the result is not ready for DIY use – it shows a promising way to get brain‑active peptides across the blood‑brain barrier, but the formulation and injection method are experimental and require further development before any human protocol can be suggested.

Summary

Scientists made tiny particles that can carry a melanin‑stimulating hormone fragment (NDP‑MSH) into the brain of rats, and this helped reverse memory problems caused by a high‑fat diet and inflammation. The particles can cross the blood‑brain barrier and reach hippocampal neurons, but the work is still in early animal testing.

Abstract

This study aimed to develop polysorbate 80-coated chitosan nanoparticles (PS80/CS NPs) as a delivery system for improved brain targeting of α-Melanocyte Stimulating Hormone analog (NDP-MSH). Chitosan nanoparticles loaded with NDP-MSH were surface-modified with polysorbate 80 ([NDP-MSH]-PS80/CS NP), which formed a flattened layer on their surface. Nanoparticle preparation involved ionic gelation, followed by characterization using scanning electron microscopy (SEM) for morphology, dynamic light scattering (DLS) for colloidal properties, and ATR-FTIR spectroscopy for structure. Intraperitoneal injection of FITC-PS80/CS NPs and [NDP-MSH]-PS80/CS NP in rats demonstrated their ability to cross the blood-brain barrier, reach the brain, and accumulate in CA1 neurons of the dorsal hippocampus within 2 h. Two experimental models of neuroinflammation were employed with Male Wistar rats: a short-term model involving high-fat diet (HFD) consumption for 5 days followed by an immune stimulus with LPS, and a long-term model involving HFD consumption for 8 weeks. In both models, [NDP-MSH]-PS80/CS NPs could reverse the decreased expression of contextual fear memory induced by the diets. These findings suggest that [NDP-MSH]-PS80/CS NPs offer a promising strategy to overcome the limitations of NDP-MSH regarding pharmacokinetics and enzymatic stability. By facilitating NDP-MSH delivery to the hippocampus, these nanoparticles can potentially mitigate the cognitive impairments associated with HFD consumption and neuroinflammation.

Study Information

Provider

pubmed

Year

2024

Date

2024-04-28T00:00:00.000Z

DOI

10.1016/j.neuropharm.2024.109969

Citations

2

References

48